These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 535326)

  • 1. [Controlled clinical evaluation of the therapeutic effectiveness of AICA orotate in chronic hepatitis].
    Roda E; Sama C; Festi D
    Clin Ter; 1979 Jun; 89(5):489-93. PubMed ID: 535326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trials of Aicamin].
    Azzena D; Trasciatti S; Capuzzo R
    Minerva Dietol Gastroenterol; 1977; 23(4):345-51. PubMed ID: 349423
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical studies on the liver-protective effect of 4-amino-5-imidazole carboxamide and orotic acid].
    Fehér VJ; Jakab L; Tenczer J; Szilvási I
    Dtsch Z Verdau Stoffwechselkr; 1977; 37(4):175-9. PubMed ID: 75788
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of AICA orotate in hepatitis and cirrhosis].
    Chanoine F
    Acta Gastroenterol Belg; 1969; 32(4-5):383-95. PubMed ID: 4927897
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic activity of 2,4-dihydroxy-6-pyrimidine carbonate of 4-amino-5-carbamide-imidazole].
    Pasotti C
    Clin Ter; 1975 Nov; 75(3):281-9. PubMed ID: 776509
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ureidosuccinate of 5(4)amino-4(5)imidazolecarboxamide: biopsy study after "controlled" use of the new substance in hepatic therapy].
    Cavazzuti F
    Clin Ter; 1977 Nov; 83(3):243-77. PubMed ID: 603982
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current problems in the treatment of hepatic cirrhosis].
    Oancea R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(4):303-10. PubMed ID: 6173910
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE PHARMACOLOGICAL ACTIVITY OF AICA OROTATE IN VARIOUS SKIN DISEASES].
    MIYAZAWA T; KUMASAKA S
    Hifuka Kiyo; 1965 Feb; 60():76-84. PubMed ID: 14286713
    [No Abstract]   [Full Text] [Related]  

  • 9. [AICA OROTATE, A NUCLEIC ACID PRECURSOR, IN THE TREATMENT OF MALE STERILITY].
    MORI A; HARA S; NISHIGAKI S; CHOKYU K
    Hinyokika Kiyo; 1963 Aug; 9():460-5. PubMed ID: 14051178
    [No Abstract]   [Full Text] [Related]  

  • 10. [Some results of treatment of chronic hepatitis with potassium orotate (first preliminary report)].
    Brailski Kh; Kolarski V; Mendizova A
    Vutr Boles; 1972; 11(6):69-73. PubMed ID: 4680044
    [No Abstract]   [Full Text] [Related]  

  • 11. [Controlled clinical trial of 5(4)-amino-4(5)-imidazole carboxyamide ureidosuccinate, a new hepatic therapeutic agent stimulating liver regeneration and protein anabolism].
    Busin S; Micheli PL; Sovera A
    Clin Ter; 1977 Dec; 83(5):483-529. PubMed ID: 343971
    [No Abstract]   [Full Text] [Related]  

  • 12. [Imidazole nucleosides, III. Nucleosides of 4(5)-aminoimidazole-5(4)-carboxamide (author's transl)].
    Guglielmi H; Jung A
    Hoppe Seylers Z Physiol Chem; 1977 Nov; 358(11):1463-8. PubMed ID: 924368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent controlled studies on the therapy of malignant melanoma].
    Canavese G; Margarino G
    Minerva Med; 1982 Dec; 73(48):3458-60. PubMed ID: 6757800
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experimentation with Aïcamine in hepatic insufficiency].
    Négret JP
    Bord Med; 1972 Apr; 5(8):973-6. PubMed ID: 5053280
    [No Abstract]   [Full Text] [Related]  

  • 15. [A.I.C.A. orotate in hepatic pathology].
    Monges H; Salducci J
    Therapeutique; 1969 Nov; 45(9):911-2. PubMed ID: 4904999
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver cell protection in toxic liver lesion.
    Fehér J; Cornides A; Pál J; Láng I; Csomós G
    Acta Physiol Hung; 1989; 73(2-3):285-91. PubMed ID: 2596318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICA-riboside) as a targeting agent for therapy of patients with acute lymphoblastic leukemia: are we there and are there pitfalls?
    Cronstein BN; Kamen BA
    J Pediatr Hematol Oncol; 2007 Dec; 29(12):805-7. PubMed ID: 18090925
    [No Abstract]   [Full Text] [Related]  

  • 18. Experiences with Catergen treatment in chronic active hepatitis.
    Pár A; Paál M; Kádas I; Nagy I; Kerekes E; Jávor T
    Ther Hung; 1983; 31(3):105-14. PubMed ID: 6400472
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immuno- and chemoimmunotherapy and prevention of metastasis in skin melanoma].
    Trapeznikov NN; Iavorskiĭ VV; Vagner RI; Gorodilova VV; Knysh IT
    Vestn Akad Med Nauk SSSR; 1978; (5):19-26. PubMed ID: 676458
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current views on the liver-protective therapy: clinical evaluation of 4-amino-5-carbamide imidazole 2,4-dihydroxy-6-pyrimidine carbonate].
    Tàmmaro AE; Bonaccorso O
    Clin Ter; 1975 Oct; 75(2):141-51. PubMed ID: 1227763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.